Clinical Trial Update: Safety and Immune Response Study of an Investigational Pneumococcal Vaccine. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immune response of an investigational pneumococcal vaccine has completed. The study was sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Investigational pneumococcal vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prophylactic Pneumococcal Diseases | Phase 2 | Status: COMPLETED